Literature DB >> 2690922

Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo.

T Zagulski1, P Lipiński, A Zagulska, S Broniek, Z Jarzabek.   

Abstract

Experiments were undertaken to demonstrate and partially explain the protective effect of bovine lactoferrin (LB) when administered intravenously to mice 24 h before a challenge with a lethal dose of Escherichia coli. About 70% of mice pretreated with LB survived challenge. The survival rates in control mice treated with E. coli alone and pretreated with bovine serum albumin (BSA), were 4 and 8%, respectively. Human lactoferrin (LH) had almost the same protective effect as LB. Sufficient amounts of ferric ions were given to mice, in single and multiple doses, for full serum transferrin saturation 30 min before or after E. coli administration. The multiple dose of ferric ions did not change considerably the survival rate of mice pretreated with LB. In contrast, a single dose of ferric ions gradually decreased the survival rate of the mice after the first week of experiment. From day 14 this decrease was statistically significant in all groups of mice treated with a single dose of ferric ions when compared with mice pretreated only with LB, and the difference ranged from 25 to 35% on day 30. The possible mechanism(s) of protective effect of LB and role of iron ions are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690922      PMCID: PMC2040730     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  19 in total

1.  Recombinant human tumor necrosis factor depresses serum iron in mice.

Authors:  T Tanaka; E Araki; K Nitta; M Tateno
Journal:  J Biol Response Mod       Date:  1987-10

Review 2.  Iron and susceptibility to infectious disease.

Authors:  E D Weinberg
Journal:  Science       Date:  1974-05-31       Impact factor: 47.728

3.  Inhibition of bacteria by lactoferrin and other iron-chelating agents.

Authors:  J D Oram; B Reiter
Journal:  Biochim Biophys Acta       Date:  1968-12-23

4.  Lactoferrin-mediated modulation of mononuclear cell activities. I. Suppression of the murine in vitro primary antibody responses.

Authors:  R L Duncan; W P McArthur
Journal:  Cell Immunol       Date:  1981-09-15       Impact factor: 4.868

Review 5.  Iron withholding: a defense against infection and neoplasia.

Authors:  E D Weinberg
Journal:  Physiol Rev       Date:  1984-01       Impact factor: 37.312

6.  Improved microtechnique for endotoxin assay by the Limulus amebocyte lysate test.

Authors:  A Gardi; G R Arpagaus
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

7.  A subpopulation of human polymorphonuclear neutrophils contains an active form of lactoferrin capable of binding to human monocytes and inhibiting production of granulocyte-macrophage colony stimulatory activities.

Authors:  H E Broxmeyer; P Ralph; J Bognacki; P W Kincade; M Desousa
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

8.  Lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia.

Authors:  H E Broxmeyer; P Gentile; J Bognacki; P Ralph
Journal:  Blood Cells       Date:  1983

9.  Interleukin 1-induced depression of iron and zinc: role of granulocytes and lactoferrin.

Authors:  S E Goldblum; D A Cohen; M Jay; C J McClain
Journal:  Am J Physiol       Date:  1987-01

10.  The involvement of lactoferrin in the hyposideremia of acute inflammation.

Authors:  J L Van Snick; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Lactoferrin and prematurity: a promising milk protein?

Authors:  Theresa J Ochoa; Stéphane V Sizonenko
Journal:  Biochem Cell Biol       Date:  2016-10-26       Impact factor: 3.626

2.  Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice.

Authors:  M L Kruzel; Y Harari; C Y Chen; G A Castro
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

Review 3.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

4.  The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets.

Authors:  W J Lee; J L Farmer; M Hilty; Y B Kim
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.

Authors:  Kathryn A Patras; Albert D Ha; Emma Rooholfada; Joshua Olson; Satish P Ramachandra Rao; Ann E Lin; Victor Nizet
Journal:  J Innate Immun       Date:  2019-05-03       Impact factor: 7.349

6.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Human lactoferrin induces phenotypic and functional changes in murine splenic B cells.

Authors:  M Zimecki; J Mazurier; G Spik; J A Kapp
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

Review 8.  Lactoferrin for prevention of neonatal sepsis.

Authors:  Christie G Turin; Alonso Zea-Vera; Alonso Pezo; Karen Cruz; Jaime Zegarra; Sicilia Bellomo; Luis Cam; Raul Llanos; Anne Castañeda; Lourdes Tucto; Theresa J Ochoa
Journal:  Biometals       Date:  2014-06-17       Impact factor: 2.949

Review 9.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.